PDF of Trial CTRI Website URL -

Size: px
Start display at page:

Download "PDF of Trial CTRI Website URL -"

Transcription

1 Clinical Trial Details (PDF Generation Date :- Fri, 04 Jan :47:10 GMT) CTRI Number Last Modified On 25/04/2017 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study Scientific Title of Study CTRI/2017/04/ [Registered on: 27/04/2017] - Trial Registered Prospectively No Interventional Drug Randomized, Parallel Group Trial New treatment regimens for treatment of Post Kala Azar Dermal Leishmaniasis patients in and Bangladesh region An Open label, Randomized, Clinical Trial of Two Regimens to Assess the Safety and Efficacy for Treatment of PKDL Patients in the n subcontinent Secondary IDs if Any Secondary ID Identifier Details of Principal Investigator or overall Trial Coordinator (multi-center study) Details Contact Person (Scientific Query) Details Contact Person (Public Query) DNDi-MILT COMB-01-PKDL, version 1, date 09 February 2017 Protocol Number Details of Principal Investigator Prof Shyam Sundar Principal Investigator Phone Institute of Medical Sciences, Banaras Hindu University Professor of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi , Varanasi UTTAR PRADESH drshyamsundar@hotmail.com Details Contact Person (Scientific Query) Dr Vishal Goyal Phone Senior clinical Manager Drugs for Neglected Diseases initiative Drugs for Neglected Diseases initiative, PHD Chambers, 4/2 Siri Institutional Area New Delhi DELHI New Delhi DELHI vgoyal@dndi.org Details Contact Person (Public Query) Dr Vishal Goyal Senior clinical Manager Drugs for Neglected Diseases initiative Drugs for Neglected Diseases initiative, PHD Chambers, 4/2 Siri Institutional Area New Delhi DELHI New Delhi DELHI page 1 / 5

2 Source of Monetary or Material Support Primary Sponsor Details of Secondary Sponsor Countries of Recruitment Sites of Study Details of Ethics Committee Regulatory Clearance Status from DCGI Health Condition / Problems Studied Intervention / Comparator Agent Phone vgoyal@dndi.org Source of Monetary or Material Support > Drugs for Neglected Diseases initiative (DNDi, Chemin Louis Dunant, 15, 1202 Geneva, Switzerland Type of Sponsor NIL List of Countries Bangladesh of Principal Investigator Prof Shyam Sundar Dr Krishna Pandey Primary Sponsor Details Drugs for Neglected Diseases initiative DNDi 15, Chemin Louis-Dunant, 1202, Geneva-Switzerland Other [Not for Profit Organisation] NIL of Site Site Phone// Research Centre Rajendra Memorial Medical Sciences Research Centre Rambag Road Muzzarpur, Bihar , Muzaffarpur BIHAR drshyamsundar@hotma il.com Rajendra Memorial Medical Sciences Agam drkrishnapandey@yaho Kuan, Patna, Bihar o.com , Patna BIHAR of Committee Approval Status Date of Approval Is Independent Ethics Committee? Research Centre - Muzzafarpur Rajendra Memorial Medical Sciences Ethic Committee - Patna Status Not Applicable Health Type Patients Approved 02/04/2017 No Approved 04/03/2017 No Date No Date Specified Condition Post Kala Azar Dermal Leishmaniasis Type Details Intervention Liposomal Amphotericin B (Ambisome ) Ambisome monotherapy regimen (5 x 4 mg/kg IV, twice per week, total dose of 20 mg/kg) Total duration of 15 days (Ambisome injections at D1, D4, D8, D11, D15) page 2 / 5

3 Inclusion Criteria Intervention Liposomal Amphotericin B (Ambisome ) Miltefosine Comparator Agent Not Applicable Not Applicable Age From Age To Gender Details 6.00 Year(s) Year(s) Both Inclusion Criteria Combintaion of Ambisome (5 x 4 mg/kg IV, twice per week, total dose of 20 mg/kg) with miltefosine allometric dose orally for three weeks 1. Confirmed PKDL case by clinical presentation and demonstration of parasites by microscopy in a skin smear or biopsy or by qpcr, with stable or progressive disease for at least 4 months 2. Male or Female patients aged 6 to 60 years 3. Written voluntarily informed consent from adult patient and from parent / guardian in case of children 19-years old 5. Patients with haemoglobin 6. Patients with abnormal liver function (ALT and AST) tests of more than three times the normal range. 7. Patients with total bilirubin levels >1.5 times the upper normal range 8. Patients with serum creatinine above the upper normal range 9. Patients with serum potassium 10. Patients with a positive HIV test as applicable 11. Patients / guardian not willing to participate 12. Patients with history of allergy or hypersensitivity to the relevant study drug 13. Patients on immunomodulators Method of Generating Random Sequence Method of Concealment Blinding/Masking Computer generated randomization Sequentially numbered, sealed, opaque envelopes Open Label Primary Outcome Outcome Timepoints To measure the efficacy (definitive cure at 12 months) of two treatment regimens in subjects with PKDL according to clinical criteria: complete resolution of papular and nodular lesions (flattening of 100% of lesions) and significant improvement ( 80% re-pigmentation) of macular lesions by 12 months after the end of treatment. Follow up patients by 12 months after the end of treatment. Secondary Outcome Outcome Timepoints To assess the maximal accumulation of total Follow up patients by 12 months after the end of amphotericin B and miltefosine in the skin at the treatment. end of treatment and correlate these with plasma levels. To assess the change in immune response during and after end of treatment as compared to baseline by measuring cytokines profiles level in the peripheral blood. To assess the clearance of parasites by microscopy and qpcr at various time-points before, during and after treatment and during follow-up Target Sample Size Total Sample Size=110 page 3 / 5

4 Phase of Trial Phase 2 Date of First Enrollment () Date of First Enrollment (Global) Estimated Duration of Trial Recruitment Status of Trial (Global) Recruitment Status of Trial () Publication Details Brief Summary Sample Size from =80 20/06/ /06/2017 Years=2 Months=0 Days=0 Not Yet Recruiting Not Yet Recruiting Not Applicable as of now This is a non-comparative, open label, randomized phase II clinical trial to assess the safety and efficacy of Ambisome monotherapy (5 x 4 mg/kg IV given twice per week at a total dose of 20 mg/kg given) and a combination of Ambisome (5 x 4 mg/kg IV given twice per week at a total dose of 20 mg/kg) plus miltefosine orally daily (allometric dosing BID) for three weeks for PKDL patients in and Bangladesh. Participating Sites: In order to have representatives of PKDL patients from different countries, this study will be conducted at 2 sites in Rajendra Memorial Medical Sciences (ICMR Institute) at Patna, Bihar and Research Centre, Muzzafarpur and at one site in Bangladesh - International Centre for Diarrhoeal Disease Research. Study Drugs: Study drugs used in the study are Ambisome and Miltefosine that are currently procured by and being used within the GoI National Programme for treatment of Kala Azar. Both drugs being used in the study have been extensively researched for use in the treatment of visceral leishmaniasis in, and are currently approved and being used by the National Vector Borne Disease Control program for the treatment of Kala Azar. Rationale: This study aims primarily to improve current treatment options. Currently there are no satisfactory treatments for any forms of PKDL. Conventional amphotericin B has been used in for prolonged periods (60 infusions) but this is impractical and requires careful clinical and biochemical monitoring. Both miltefosine and Ambisome as monotherapy have shown to be effective. However, with the current recommended schemes there are some drawbacks such as the length of the treatment with miltefosine alone (12 weeks); the costs and recently observed toxicity of a high dose Ambisome (total dose of 30 mg/kg). There is also the potential risk for development of resistance with miltefosine as monotherapy. PKDL is a disease of major public health importance post- visceral leishmaniasis, as it is thought that PKDL could be a reservoir of Leishmania donovani infection and hence transmit VL. Obviously this is of crucial importance in the current VL elimination efforts in the n subcontinent. The study is being conducted solely to provide better evidence for the GoI in order to treat PKDL patients more effectively as part of the National Kala Azar Elimination Programme. General Objectives: The overall objective of this study is to assess the safety and efficacy of two treatment modalities for PKDL patients in n Subcontinent (ISC). Primary Objective: To measure the safety and efficacy of Ambisome monotherapy regimen (5 x 4 mg/kg IV, twice per week, total dose of 20 mg/kg) and Ambisome (5 x 4 mg/kg IV, twice per week, total dose of 20 mg/kg) in combination with miltefosine orally daily for three weeks (allometric dosing), for PKDL patients in the ISC. Secondary Objectives To assess skin and plasma concentrations of total Ambisome and miltefosine. To evaluate the host immune response in each treatment arm before, during and after page 4 / 5

5 Powered by TCPDF ( PDF of Trial treatment. To evaluate parasite clearance in each arm as indicated by direct microscopy and qpcr To assess relationship between clinical, parasitological and immunological responses to identify a potential biomarker for cure To assess relationship between pharmacokinetic parameters with clinical outcome and parasite clearance Primary Endpoint Efficacy: To measure the efficacy (definitive cure at 12 months) of two treatment regimens in subjects with PKDL according to clinical criteria: complete resolution of papular and nodular lesions (flattening of 100% of lesions) and significant improvement (> 80% re-pigmentation) of macular lesions by 12 months after the end of treatment. Safety: To assess the safety of the two regimens (SAEs and frequency and severity of AEs) from the start of treatment through the 12-month follow-up period. Secondary Endpoint(s) Pharmacokinetics: To assess the maximal accumulation of total amphotericin B and miltefosine in the skin at the end of treatment and correlate these with plasma levels. Immune Response: To assess the change in immune response during and after end of treatment as compared to baseline by measuring cytokines profiles level in the peripheral blood. Parasitology: To assess the clearance of parasites by microscopy and qpcr at various time-points before, during and after treatment and during follow-up. page 5 / 5

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 06 Oct 2018 18:04:10 GMT) CTRI Number Last Modified On 02/06/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 26 Oct 2018 15:38:49 GMT) CTRI Number Last Modified On 12/12/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 08 Jan 2019 13:37:20 GMT) CTRI Number Last Modified On 23/11/2011 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Thu, 22 Nov 2018 04:49:28 GMT) CTRI Number Last Modified On 25/04/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 17 Mar 2019 16:13:06 GMT) CTRI Number Last Modified On 09/05/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Visceral Leishmaniasis combination therapies

Visceral Leishmaniasis combination therapies Best Science for the Most Neglected From patient needs to implementation of new treatments Visceral Leishmaniasis combination therapies Shyam Sundar Institute of Medical Sciences Banaras Hindu University

More information

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial Tropical Medicine and International Health doi:10.1111/tmi.12015 volume 18 no 1 pp 96 100 january 2013 Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial Shyam Sundar 1,

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Thu, 18 Oct 2018 14:39:26 GMT) CTRI Number Last Modified On 06/04/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 14 Jan 2019 04:12:22 GMT) CTRI Number Last Modified On 25/08/2011 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 19 Dec 2018 02:45:15 GMT) CTRI Number Last Modified On 25/12/2017 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India

Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis Shyam Sundar Banaras Hindu University Varanasi, India History of the Current Epidemic in India & Antimony Resistance 6 Official

More information

Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis

Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis ISRN Parasitology, Article ID 548010, 4 pages http://dx.doi.org/10.1155/2014/548010 Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis Shyam Sundar,

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 09 Apr 2019 10:09:21 GMT) CTRI Number Last Modified On 18/09/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 28 Nov 2018 03:21:14 GMT) CTRI Number Last Modified On 30/09/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 17 Mar 2019 01:47:34 GMT) CTRI Number Last Modified On 05/06/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Dr Monique Wasunna MBChB, PhD, DTM&H DNDi Africa Regional office. WorldLeish6 Congress, Toledo Spain

Dr Monique Wasunna MBChB, PhD, DTM&H DNDi Africa Regional office. WorldLeish6 Congress, Toledo Spain Phase II Randomized Clinical Trial of the Efficacy and Safety of AmBisome in Combination with SSG or Miltefosine versus Miltefosine Monotherapy for African VL Dr Monique Wasunna MBChB, PhD, DTM&H DNDi

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 30 Dec 2018 00:34:16 GMT) CTRI Number CTRI/2009/091/000652 [Registered on: 27/10/2009] - Last Modified On 11/03/2014 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 15 Jan 2019 07:37:18 GMT) CTRI Number Last Modified On 26/03/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

REF/2011/11/ CTRI Website URL -

REF/2011/11/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 24 Nov 2017 03:47:32 GMT) CTRI Number Last Modified On 15/01/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

REF/2012/08/ CTRI Website URL -

REF/2012/08/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 11 May 2018 23:49:14 GMT) CTRI Number Last Modified On 03/05/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 08 Mar 2019 04:26:40 GMT) CTRI Number Last Modified On 14/02/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 19 Mar 2019 18:08:08 GMT) CTRI Number CTRI/2009/091/000355 [Registered on: 22/01/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 07 Dec 2018 19:05:34 GMT) CTRI Number CTRI/2009/091/000669 [Registered on: 01/12/2009] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 01 Dec 2018 00:07:49 GMT) CTRI Number CTRI/2010/091/000387 [Registered on: 20/05/2010] - Last Modified On 15/03/2013 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 21 Nov 2018 00:19:07 GMT) CTRI Number CTRI/2010/091/000067 [Registered on: 10/02/2010] - Last Modified On 12/03/2013 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 14 Apr 2019 16:03:43 GMT) CTRI Number Last Modified On 30/10/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 09 Apr 2019 13:19:44 GMT) CTRI Number CTRI/2010/091/000149 [Registered on: 17/02/2010] - Last Modified On 11/04/2013 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 17 Nov 2018 14:20:06 GMT) CTRI Number Last Modified On 10/05/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 17 Jul 2018 08:11:24 GMT) CTRI Number Last Modified On 10/06/2017 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 23 Nov 2018 06:48:34 GMT) CTRI Number Last Modified On 18/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 28 Nov 2018 03:04:58 GMT) CTRI Number CTRI/2009/091/000771 [Registered on: 28/10/2009] - Last Modified On 08/09/2014 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 08 Mar 2019 06:06:36 GMT) CTRI Number CTRI/2010/091/000514 [Registered on: 25/05/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

Elimination of VL in the Indian subcontinent is it achievable?

Elimination of VL in the Indian subcontinent is it achievable? Elimination of VL in the Indian subcontinent is it achievable? P Das Rajendra Memorial Research Institute, Patna Jorge Alvar DNDi, Geneva Bhawna Sharma DNDi, India Leishmaniasis 350 million at risk worldwide

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 19 Apr 2019 13:49:20 GMT) CTRI Number CTRI/2009/091/000126 [Registered on: 15/04/2009] - Last Modified On 03/09/2014 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 23 Feb 2019 02:27:19 GMT) CTRI Number CTRI/2009/091/000044 [Registered on: 17/02/2009] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 11 Jan 2019 14:23:08 GMT) CTRI Number Last Modified On 23/04/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 25 Jul 2018 13:50:16 GMT) CTRI Number Last Modified On 10/05/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 17 Jul 2018 00:15:16 GMT) CTRI Number Last Modified On 01/02/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 17 Apr 2019 02:24:18 GMT) CTRI Number Last Modified On 16/08/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 15 Mar 2019 21:54:24 GMT) CTRI Number Last Modified On 29/10/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 06 Nov 2018 17:16:00 GMT) CTRI Number Last Modified On 03/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 06 Jan 2019 11:39:39 GMT) CTRI Number Last Modified On 15/02/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 07 Apr 2019 21:50:45 GMT) CTRI Number Last Modified On 11/03/2019 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

REF/2014/03/ CTRI Website URL -

REF/2014/03/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 28 Feb 2018 22:13:58 GMT) CTRI Number Last Modified On 13/02/2017 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 03 Nov 2018 05:20:48 GMT) CTRI Number Last Modified On 12/12/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 07 Jul 2018 14:19:46 GMT) CTRI Number Last Modified On 04/07/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 09 Nov 2018 00:53:13 GMT) CTRI Number Last Modified On 30/07/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 08 Mar 2019 15:58:14 GMT) CTRI Number Last Modified On 26/12/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 03 Dec 2018 14:24:00 GMT) CTRI Number Last Modified On Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study Scientific

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 12 Dec 2018 14:35:45 GMT) CTRI Number Last Modified On 15/01/2013 Post Graduate Thesis Type of Trial Type of Study Study Design CTRI/2011/12/002273 [Registered

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 01 Jan 2019 02:42:38 GMT) CTRI Number CTRI/2008/091/000063 [Registered on: 08/07/2008] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment

Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment MAJOR ARTICLE Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment Shyam Sundar, Neha Agrawal, Rakesh Arora, Dipti Agarwal, Madhukar Rai, and Jaya Chakravarty

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Thu, 17 Jan 2019 04:33:43 GMT) CTRI Number Last Modified On 26/06/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 22 Aug 2018 08:47:30 GMT) CTRI Number CTRI/2009/091/000605 [Registered on: 18/01/2011] - Last Modified On 15/02/2013 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 03 Sep 2018 18:46:09 GMT) CTRI Number Last Modified On 18/07/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 21 Jan 2019 19:40:34 GMT) CTRI Number CTRI/2009/091/000051 [Registered on: 08/04/2009] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE

POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE American Journal of Infectious Diseases 10 (2): 50-55, 2014 ISSN: 1553-6203 2014 Science Publication doi:10.3844/ajidsp.2014.50.55 Published Online 10 (2) 2014 (http://www.thescipub.com/ajid.toc) POST

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 20 Jan 2019 21:39:27 GMT) CTRI Number CTRI/2009/091/000777 [Registered on: 11/01/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 11:16:02 GMT) CTRI Number CTRI/2009/091/000668 [Registered on: 11/01/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 17 Mar 2019 03:23:33 GMT) CTRI Number Last Modified On 03/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 07 Apr 2019 02:55:48 GMT) CTRI Number CTRI/2009/091/000750 [Registered on: 09/10/2009] - Last Modified On 14/08/2014 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 17 Apr 2019 04:44:33 GMT) CTRI Number Last Modified On 28/01/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 27 Mar 2019 20:50:17 GMT) CTRI Number CTRI/2009/091/001039 [Registered on: 15/10/2010] - Last Modified On 11/06/2015 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 12 Sep 2018 12:18:27 GMT) CTRI Number Last Modified On 04/07/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 22 Feb 2019 22:24:32 GMT) CTRI Number Last Modified On 06/11/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 31 Dec 2018 05:20:34 GMT) CTRI Number CTRI/2010/091/000109 [Registered on: 03/08/2010] - Last Modified On 07/04/2011 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 17 Jul 2018 00:15:15 GMT) CTRI Number CTRI/2010/091/001049 [Registered on: 28/06/2010] - Last Modified On 01/02/2013 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 12 Apr 2019 07:28:50 GMT) CTRI Number Last Modified On 18/05/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 08 Mar 2019 23:58:25 GMT) CTRI Number CTRI/2009/091/000399 [Registered on: 17/11/2009] - Last Modified On 15/01/2015 Post Graduate Thesis Type of Trial

More information

Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study

Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study MAJOR ARTICLE Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study S. Sundar, 1 T. K. Jha, 2 C. P. Thakur, 3 M. Mishra, 4 V. P. Singh, 1 and R.

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 09 Mar 2019 16:29:06 GMT) CTRI Number CTRI/2010/091/000679 [Registered on: 23/08/2010] - Last Modified On 10/07/2015 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 09 Nov 2018 18:49:36 GMT) CTRI Number CTRI/2010/091/001300 [Registered on: 05/10/2010] - Last Modified On 12/03/2013 Post Graduate Thesis Type of Trial

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 28 Sep 2018 17:28:30 GMT) CTRI Number Last Modified On 25/10/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 09 Oct 2018 14:20:31 GMT) CTRI Number Last Modified On 23/07/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

REF/2014/10/ CTRI Website URL -

REF/2014/10/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 16 Dec 2017 12:41:27 GMT) CTRI Number Last Modified On 16/04/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 08 Mar 2019 05:39:17 GMT) CTRI Number Last Modified On 21/11/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 22:54:26 GMT) CTRI Number Last Modified On 11/05/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

A Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by. rk39 Test in Sputum Samples

A Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by. rk39 Test in Sputum Samples JCM Accepts, published online ahead of print on 0 June 00 J. Clin. Microbiol. doi:0./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 12 Apr 2019 04:54:41 GMT) CTRI Number Last Modified On 03/12/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

CTRI Dataset and Description

CTRI Dataset and Description CTRI Dataset and Description CTRI Field Description Public title of study Title intended for the lay public in easily understood language. Example: A clinical trial to study the effects of two drugs, ramipril

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 17 Mar 2019 14:52:10 GMT) CTRI Number CTRI/2010/091/003032 [Registered on: 30/11/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 05 Oct 2018 20:16:50 GMT) CTRI Number Last Modified On 07/08/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 25 Nov 2018 12:22:24 GMT) CTRI Number Last Modified On 06/07/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

by author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018

by author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018 Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018 Dr. Monique Wasunna, Director, DNDi Africa Regional Office Presentation Outline 1 2 4 5 Introduction leishmaniasis

More information

REF/2012/01/ CTRI Website URL -

REF/2012/01/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 05 May 2018 05:20:32 GMT) CTRI Number Last Modified On 06/04/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Application for Inclusion of MILTEFOSINE on WHO Model List of Essential Medicines:

Application for Inclusion of MILTEFOSINE on WHO Model List of Essential Medicines: Application for Inclusion of MILTEFOSINE on WHO Model List of Essential Medicines: Comments re Feb 2011 reviews of the v 2010 application February 23, 2011 1. The application and its review In v 2010,

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 15 Jun 2018 08:45:14 GMT) CTRI Number CTRI/2010/091/000528 [Registered on: 12/07/2010] - Last Modified On 07/10/2014 Post Graduate Thesis Type of Trial

More information

Kala-Azar- Treatment Update

Kala-Azar- Treatment Update JOURNAL OF ADVANCES IN MEDICINE (JAM) DOI: 10.5958/2319-4324.2016.00002.X REVIEW PAPER Kala-Azar- Treatment Update Anup Singh Associate Professor, Department of Medicine, Institute of Medical Sciences,

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Fri, 09 Nov 2018 19:32:51 GMT) CTRI Number Last Modified On 23/08/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Drug resistance in Indian visceral leishmaniasis

Drug resistance in Indian visceral leishmaniasis Tropical Medicine and International Health volume6no11pp849±854november2001 Drug resistance in Indian visceral leishmaniasis Shyam Sundar Kala-azar Medical Research Centre, Banaras Hindu University, Varanasi,

More information

REFCTRI/2010/ CTRI Website URL -

REFCTRI/2010/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 23 Apr 2018 20:30:46 GMT) CTRI Number CTRI/2010/091/000460 [Registered on: 15/10/2010] - Last Modified On 17/04/2012 Post Graduate Thesis Type of Trial

More information

REF/2012/12/ CTRI Website URL -

REF/2012/12/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 08 May 2018 01:58:26 GMT) CTRI Number Last Modified On 13/02/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Tue, 25 Dec 2018 01:08:22 GMT) CTRI Number Last Modified On 08/05/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information